These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 8079303)

  • 1. [Mass vaccination against tuberculosis--is it necessary in Norway?].
    Eskild A
    Tidsskr Nor Laegeforen; 1994 Jun; 114(16):1840-4. PubMed ID: 8079303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries.
    Brantsaeter AB; Romanus V; Andersen PH; Heldal E
    Int J Tuberc Lung Dis; 2009 Apr; 13(4):440-5. PubMed ID: 19335948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Where do we stand with BCG vaccination programme in Japan?].
    Mori T
    Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six years' experience with the discontinuation of BCG vaccination. 2. Cost and benefit of mass BCG vaccination.
    Trnka L; Danková D; Svandová E
    Tuber Lung Dis; 1993 Aug; 74(4):288-92. PubMed ID: 8219182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Policy program to minimize spread of infection. Prolonged cough may be a sign of tuberculosis].
    Fredlund H; Larsson LO; Blom-Bülow B; Julander I; Normann B; Romanus V; Wahlström H
    Lakartidningen; 1998 Mar; 95(10):1010-2, 1015-6. PubMed ID: 9528251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contemporary status of BCG vaccine in the world and in Serbia].
    Pesut D
    Med Pregl; 2004; 57 Suppl 1():37-40. PubMed ID: 15686220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tuberculosis control in Scandinavia].
    Romanus V; Tala E; Blöndal T; Heldal E; Poulsen S
    Nord Med; 1995; 110(2):45-7. PubMed ID: 7854909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six years' experience with the discontinuation of BCG vaccination. 1. Risk of tuberculosis infection and disease.
    Trnka L; Danková D; Svandová E
    Tuber Lung Dis; 1993 Jun; 74(3):167-72. PubMed ID: 8369510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology of childhood tuberculosis in the Basque Autonomous Community 1980-89. Efficacy of BCG vaccination].
    Errezola Saizar M; Arístegui Fernández J; Gutiérrez Villamayor C; Pérez Díaz L; Zubillaga Huici P
    An Esp Pediatr; 1992 Mar; 36(3):177-80. PubMed ID: 1580424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccine prophylaxis of tuberculosis: implication and problems].
    Aksenova VA; Levi DT; Fonina EV; Vundtsettel' NN
    Probl Tuberk Bolezn Legk; 2009; (1):10-6. PubMed ID: 19253677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mass vaccination against tuberculosis--do we need it in Norway?].
    Skarpaas IJ
    Tidsskr Nor Laegeforen; 1994 Sep; 114(23):2751. PubMed ID: 7998020
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment.
    Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J
    Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The place of BCG vaccination in the fight against tuberculosis].
    Sickenga FN
    Ned Tijdschr Geneeskd; 1969 Jun; 113(25):1107-11. PubMed ID: 5791970
    [No Abstract]   [Full Text] [Related]  

  • 15. BCG and prospects for new vaccines against tuberculosis.
    Ortona L; De Luca A
    Rays; 1998; 23(1):225-30. PubMed ID: 9673148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis: vaccines in the pipeline.
    Ly LH; McMurray DN
    Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of BCG vaccination policy in Europe: 1994-96.
    Trnka L; Dankova D; Zitova J; Cimprichova L; Migliori GB; Clancy L; Zellweger JP
    Bull World Health Organ; 1998; 76(1):85-91. PubMed ID: 9615500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
    Araujo Z; de Waard JH; de Larrea CF; Borges R; Convit J
    Vaccine; 2008 Oct; 26(44):5575-81. PubMed ID: 18723065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective BCG vaccination in a country with low incidence of tuberculosis.
    Romanus V
    Euro Surveill; 2006; 11(3):14-7. PubMed ID: 16567880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.